TESARO Summarizes TSR-042 Clinical Data Presented at AACR

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to TESARO Summarizes TSR-042 Clinical Data Presented at AACR

Tesoro (TSRO) Data Supportive of Future Combos - Cowen

April 16, 2018 12:45 PM EDT

Cowen analyst Boris Peaker reiterated a Market Perform rating and $66 price target on Tesaro (NASDAQ: TSRO) after the company reported MSI-H endometrial and NSCLC expansion cohort data for TSR-042 (anti-PD-1 mAb) at AACR.

"Response rates of 46.7% and 29.2%, respectively, appear competitive in these two... More